(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 227771 - Shigella Antiserum Polyvalent Group C1 for Laboratory Identification and Serological Testing

BD  # 227771 - Shigella Antiserum Polyvalent Group C1 for Laboratory Identification and Serological Testing
Part Number BD 227771
SKU Number CIA2544452
Sell Unit EACH
Ships Within Special Order
List Price $586.13
Enter a valid quantity
Product Description

BD 227771 - Shigella Antiserum Polyvalent Group C1 for Laboratory Identification and Serological Testing

The BD 227771 Shigella Antiserum Polyvalent Group C1 is a high-quality diagnostic reagent designed for the rapid and reliable identification of Shigella Group C1 organisms in clinical and microbiological laboratories. Developed by BD, this polyvalent antiserum contains specific antibodies that react with Group C1 Shigella antigens, enabling accurate serological confirmation through agglutination testing.

This product plays a critical role in the identification of enteric pathogens, particularly in stool culture analysis and epidemiological investigations. Its formulation ensures strong, visible agglutination reactions when the target antigen is present, supporting laboratory professionals in making precise and timely diagnostic decisions. The reagent is produced under stringent quality control conditions to ensure consistency, sensitivity, and specificity across batches.

Key Benefits

The BD 227771 antiserum provides dependable and rapid identification of Shigella Group C1 strains, helping laboratories reduce turnaround time in diagnostic workflows. Its high specificity minimizes cross-reactivity, ensuring accurate results even in complex sample environments.

The ready-to-use liquid formulation simplifies laboratory procedures, eliminating the need for additional preparation and reducing the risk of handling errors. The strong agglutination response enhances visual interpretation, allowing technicians to confidently confirm results without ambiguity.

By supporting precise pathogen identification, this product contributes to improved patient care, infection control, and public health monitoring.

Compatibility and Applications

The BD 227771 Shigella Antiserum is compatible with standard microbiological testing methods, including slide agglutination techniques commonly used in bacteriology labs. It works effectively with cultured isolates grown on selective media such as MacConkey agar or other enteric culture media.

Typical applications include clinical microbiology laboratories, hospital diagnostic centers, public health laboratories, and research institutions. It is widely used for identifying Shigella species during routine stool culture analysis, outbreak investigations, and epidemiological surveillance.

Usage Guidelines

Before use, ensure the reagent is stored according to manufacturer recommendations and has reached room temperature. Mix gently to ensure uniform distribution of antibodies without causing foam formation.

Apply a small amount of the cultured bacterial colony onto a clean slide, add a drop of the antiserum, and gently mix. Observe for visible agglutination within the recommended time frame. A positive reaction indicates the presence of Shigella Group C1 antigens.

Always include appropriate positive and negative controls to validate test accuracy. For detailed instructions, refer to the product insert provided by the manufacturer.

Certifications and Safety Standards

The BD 227771 antiserum is manufactured in compliance with internationally recognized quality standards, including ISO-certified production processes and Good Manufacturing Practices. These standards ensure consistent performance, reliability, and safety in laboratory use.

The product aligns with regulatory requirements for in vitro diagnostic reagents and may carry approvals such as FDA clearance or CE marking where applicable. These certifications confirm that the reagent meets strict quality and safety benchmarks required in clinical diagnostics.

Comparison with Competitor Products

Compared to other Shigella antisera available in the market, the BD 227771 stands out for its consistent agglutination clarity and high specificity. Many competing products may exhibit weaker reactions or higher rates of cross-reactivity, which can complicate interpretation.

BDs long-standing expertise in microbiology reagents ensures a higher level of reliability and reproducibility. Unlike some generic antisera, this product is carefully validated for performance with Group C1 antigens, making it a preferred choice for laboratories that require precise serological identification.

Its ease of use and dependable results provide a clear advantage over less standardized alternatives.

Typical User Profile and Application Scenarios

This product is primarily used by microbiologists, laboratory technicians, and clinical diagnosticians involved in bacterial identification. It is also utilized by public health professionals and researchers conducting surveillance of enteric infections.

Common scenarios include routine stool culture testing, confirmation of suspected Shigella infections, and outbreak response investigations. Laboratories handling infectious disease diagnostics benefit from the products accuracy and efficiency in identifying specific Shigella groups.

Best Practices for Use and Maintenance

To maintain optimal performance, store the antiserum under recommended temperature conditions and avoid exposure to extreme heat or freezing. Always check the expiration date before use and discard any reagent that shows signs of contamination or degradation.

Use clean slides and sterile tools to prevent cross-contamination. Avoid repeated opening of the container for prolonged periods, as this may compromise reagent stability.

Proper labeling and adherence to laboratory protocols will ensure consistent and reliable test results.

Regulatory and Safety Information

The BD 227771 Shigella Antiserum is intended for in vitro diagnostic use only and must be handled by trained laboratory personnel. Users should follow all biosafety guidelines when working with infectious samples and dispose of materials according to biohazard regulations.

Compliance with regulatory standards ensures that the product meets the necessary safety and performance requirements for use in clinical and research settings.

How to Order

Ordering the BD 227771 Shigella Antiserum Polyvalent Group C1 is simple through CIA Medical. Locate the product on the website, add it to your cart, and complete the secure checkout process.

For bulk purchasing, product inquiries, or assistance with your order, contact CIA Medical customer service at (312) 275-5850. Their team is available to support your laboratory supply needs with reliable service and expert guidance.

Related Products